2 Stocks Blasted By Options Traders

Trade tensions remain high around the U.S.-China relationship

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Opening View
OPENING VIEW
 
 

11/14/2019

Tiny Biotech Wins $75 Billion Patent


Tiny biotech firm wins $2 billion patent for new treatment that can "Cut & Paste" cancer from your body. The Wall Street Journal reports this breakthrough is "transforming medicine."

Our research proves that anyone who gets in by November 25th could turn $1,000 into $1.57 million (or more).

 unit
Stock Futures Drift Lower Despite Walmart Earnings

By Lillian Currens

Share On

Dow futures are trading lower coming off yet another record high, as tensions remain high surrounding the U.S.-China trade conflict. The anxiety is overshadowing Walmart's (WMT) third-quarter earnings beat and raised full-year forecast, with the stock up 1.7% before the open. Meanwhile, Wall Street is also keeping an eye on Fed Chair Jerome Powell's congressional testimony today, along with this morning's jobless claims update, with the number of Americans filing for unemployment benefits hitting a five-month high.

Continue reading for more on today's market, including: 

  • 2 stocks getting blasted by options bears after earnings. 
  • The technical signal that could mean even more downside for HPQ stock.
  • Plus, Goldman downgrades KHC; OPRA steps into the earnings confessional; and AOBC plans Smith & Wesson spin-off. 
>> Continue reading...
LATEST HEADLINES
>> Dow Outperforms on Disney Strength
The S&P eked out a slim gain
>> Options Traders Blast SDC amd GOOS Stocks
SDC and GOOS options volume has ramped up today
>> DDOG Stock Pops After Premier Earnings Report
Options are exchanging hands well above the average intraday pace
>> Options Premiums Attractive on Red-Hot Auto Parts Stock
Auto stocks have outperformed but put open interest is high on the group
>> Powell, Impeachment Hearings Keep Stocks at a Standstill
Procter & Gamble is keeping the Dow above water
Sponsored

Tiny Biotech Scares Big Pharma


Unknown Biotech Invents Breakthrough Colon Cancer Treatment
New medicine targets patients by their genetic profile. This new discovery threatens Big Pharma companies Pfizer and Astra Zeneca. That makes this small company our #1 Takeover Target for November.

Find out the rest of the story here >>>

 

To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions.

This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here.

For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions.

Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
Schaeffer's Opening View
SCHAEFFER'S OPENING VIEW
Posted by: at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)